Rfp Financial Group LLC Verve Therapeutics, Inc. Transaction History
Rfp Financial Group LLC
- $249 Million
- Q2 2024
A detailed history of Rfp Financial Group LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Rfp Financial Group LLC holds 3,350 shares of VERV stock, worth $24,790. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,350
Previous 3,350
-0.0%
Holding current value
$24,790
Previous $44,000
63.64%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding VERV
# of Institutions
169Shares Held
73.7MCall Options Held
125KPut Options Held
185K-
Alphabet Inc. Mountain View, CA12.3MShares$91.4 Million7.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.33MShares$46.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.37MShares$39.8 Million0.0% of portfolio
-
State Street Corp Boston, MA5.1MShares$37.7 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.58MShares$33.9 Million0.04% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $444M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...